From the Editor: Last issue, VOICE Vol. 15, No. 4, we asked Where s the Glucowatch? The Glucowatch Biographer is the almost-noninvasive blood glucose monitor we last reported as close to final approval, having been accepted by its Advisory Committee at the Food and Drug Administration. At that time, we noted final FDA approval is usually a formality, once these hurdles are past. But, as Dr. Russell Potts, Vice President for Research of CYGNUS, the GlucoWatch s manufacturer, pointed out, it is impossible to tell when the government will get around to doing something. The FDA has not yet sent CYGNUS the appropriate certificate.
On a related point, in the above article I expressed concern that the Glucowatch did not yet incorporate speech compatibility. I said Dr. Potts had not returned my calls and letters about this matter. On November 9, Dr. Potts called me, and discussed the Glucowatch, its future, and the possibility of making it adaptive for blind individuals. He apologized for not responding sooner, and said he and his company were anxious to get it out to consumers, and gain their "real world" feedback. "We have every intention of expanding its use," Dr. Potts said, "including for use by people who are sight-impaired." He stated Cygnus had to launch the basic meter before contemplating subsequent products, but their intention was to do so in the not too distant future.
For more information about the Glucowatch and its availability, contact: CYGNUS, Inc., 400 Penobscot Drive, Redwood City, CA 94063-4719; telephone: (650) 369-4300; fax: (650) 599-2503; website: www.cygn.com
Back to Top